That's a lot of risk capital for any venture-backed start-up, especially considering that not one new commercial nuclear reactor design has been approved and built in the United States for 30 years.
So expect the adjournment debate led by labour's Nia Griffiths on extending the approved use of low-dose Naltrexone to start pretty rapidly - and for the Commons to shut up shop by early afternoon, unless some other business is added.